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The mosquito-borne West Nile virus (WNV) is responsible for outbreaks of viral encephalitis
in humans and horses with particularly virulent strains causing recent outbreaks in Eastern
Europe, the Middle East, and North America. In Australia, a strain ofWNV, Kunjin (WNVKUN),
is endemic in the north and infection with this virus is generally asymptomatic. However, in
early 2011, following extensive flooding, an unprecedented outbreak ofWNVKUN encephali-
tis in horses occurred in South-Eastern Australia, resulting in more than 1,000 cases and a
mortality of 10–15%. Despite widespread evidence of equine infections, there was only a
single mild human case reported during this outbreak. To understand why clinical disease
was seen in horses without similar observations in the human population, a serosurvey
was conducted using blood donor samples from areas where equine cases were reported
to assess level of flavivirus exposure. The seroprevalence to WNVKUN in humans was
low before the outbreak (0.7%), and no significant increase was demonstrated after the
outbreak period (0.6%). Due to unusual epidemiological features during this outbreak,
a serosurvey was also conducted in rabbits, a potential reservoir host. Out of 675 ani-
mals, sampled across Australia between April 2011 and November 2012, 86 (12.7%) were
seropositive for WNVKUN, with the highest prevalence during February of 2012 (28/145;
19.3%). As this is the first serological survey for WNVKUN in Australian feral rabbits, it
remains to be determined whether wild rabbits are able to develop a high enough viremia
to actively participate inWNV transmission in Australia. However, they may constitute a sen-
tinel species for arbovirus activity, and this is the focus of on-going studies. Collectively, this
study provides little evidence of human exposure to WNVKUN during the 2011 outbreak and
indicates that the Australian population remains susceptible to the emergence of virulent
strains of WNV.
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INTRODUCTION
Flaviviruses are a group of medically important arboviruses caus-
ing large disease outbreaks around the world with approximately
50 million cases per year. Mosquito-borne flaviviruses in the
Japanese encephalitis virus (JEV) serogroup, including JEV, West
Nile virus (WNV), and Murray Valley encephalitis virus (MVEV),
cause severe, potentially fatal neurological disease in humans,
horses, and some avian species. WNV has traditionally been asso-
ciated with outbreaks of viral encephalitis in Europe and Africa
(1). In 1999, WNV appeared for the first time in the USA, associ-
ated with an outbreak of a fatal or debilitating disease in humans
and equines, and extremely high levels of morbidity and mortality
in several species of native birds in New York (2, 3). Since its intro-
duction into the USA, WNV has caused more than 16,196 human
cases of neuroinvasive disease and more than 1549 deaths in the
USA alone and spread to most parts of North, Central, and South
America via mosquito-bird transmission cycles (4).
The Kunjin strain of WNV (WNVKUN) is a closely related
virus from Australia. Although WNVKUN was initially considered
a separate species in the flavivirus genus, studies by our labo-
ratory and collaborators revealed that it shared a high degree
of antigenic and genetic homology to WNV strains, justifying
re-classification of the virus as a subtype of WNV (5–7). Until
recently, the relatively benign WNVKUN, had only been associ-
ated with a few cases of non-fatal encephalitis in humans and
a small number of equine cases since it was first isolated in
1960 (8). However, in early 2011 an unprecedented outbreak of
equine encephalitis occurred in South-East Australia, causing mor-
tality of 10–15% of horses infected (9). Upon isolation, a new
equine virulent strain of WNVKUN was confirmed, being the first
strain to cause a major outbreak in Australia (9). Symptoms of
equine infection with this strain included ataxia, muscle paral-
ysis and tremors, changes in temperament, incoordination, and
general weakness, which are consistent with clinical signs of the
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equine WNV encephalitis caused by virulent North American
(WNVNY99) and European strains (10, 11). Notably, this new
WNV strain, named WNVNSW2011, arose in regions of South-
ern Australia where WNVKUNV had not been observed previously,
including coastal and inland cities of New South Wales (NSW) (9).
Abundant rainfall in the latter half of 2010 and extending into
the first quarter of 2011 led to extensive flooding of inland areas
of NSW. This unforeseen event provided ideal climatic conditions
for breeding of freshwater mosquito populations, which recorded
a sixfold increase in number compared to the previous season
(12). This prolific population growth of the primary vector for
WNVKUN is presumed to have spurred the major outbreak in 2011
(13, 14). Nevertheless, only a small number of human infections
were recorded during the time period of the equine encephali-
tis epidemic. Perhaps even more curiously, a large number of
the equine cases occurred east of the Great Dividing Range in
the much dryer coastal regions where no flooding was experi-
enced during the same period and mosquito populations were
low (14). This prompted us to consider epidemiological factors
other than a bird–mosquito–human transmission chain. One ani-
mal species that occurs in abundance in the main affected regions
is the rabbit (Oryctolagus cuniculus). Feral rabbits have previously
been shown to sustain a brief viremia sufficient to transmit to
mosquitoes when experimentally infected with MVEV (15). Sim-
ilarly, Eastern cottontail rabbits (Sylvilagus floridanus) develop a
viremia sufficient for mosquito transmission when experimen-
tally infected with WNVNY99 (16), and preliminary work in our
group had shown that domestic rabbits (O. cuniculus) can become
infected with WNVNSW2011 (17).
We therefore carried out a serological survey on humans
from east-coast regions of NSW with high incidences of equine
encephalitis cases, using plasma samples obtained from the Aus-
tralian Red Cross Blood Service (Blood Service), to assess human
exposure during the outbreak and evaluate the on-going risk of
virulent strains of WNVKUN. In addition, we tested feral rabbits
sampled by the NSW Department of Primary Industries (NSW
DPI) from two areas in NSW and one area in all other states dur-
ing and up to 1.5 years after the equine epidemic. Collectively,
our data suggest that an overwhelming proportion of the Aus-
tralian human population remains susceptible to the emergence
of virulent strains of WNV, and that feral rabbits may repre-
sent a possible reservoir, at least in some areas of South-Eastern
Australia.
MATERIALS AND METHODS
HUMAN PLASMA SAMPLES
Plasma samples were acquired from healthy Australian blood
donors after routine infectious disease testing was complete. Sam-
ples were selected from donors residing in eastern NSW coinciding
with locations of WNVNSW2011 equine infection [Figure 1; see
also Figure 3 in Ref. (14)], with samples collected from November
2009 to November 2010 (n= 148) forming the pre-2011 sam-
ple group and those from September 2013 (n= 168) forming the
post-2011 sample group. Samples in the pre-2011 group were
collected into EDTA plasma preparation tubes [Becton, Dick-
son and Company (BD) Biosciences, San Diego, USA], while
samples collected in the post-2011 group were collected into
EDTA tubes (BD Vaccutainer® Whole Blood Collection tube).
All samples were centrifuged and plasma aliquots archived at
−30°C. Donor demographic data were obtained for each sample
(age, gender, suburb, and postcode). This study was carried out
under approval from the Blood Service Human Research Ethics
Committee.
RABBIT SERUM SAMPLES
Serum samples derived from rabbits captured or shot as part of
surveys conducted by NSW DPI in all states of Australia were
made available for testing. Collections were performed in two
central areas of NSW (Euchareena and Oaky Creek in the cen-
tral tablelands), and one area in each of the other states and the
Northern Territory (near Hattah-Kulkyne National Park in Vic-
toria; near Coorong in South Australia; south-east Queensland;
South-West Western Australia; Figure 2) during seven time peri-
ods between April 2011 (Autumn) and November 2012 (Spring).
A total of 675 samples were available for testing. The age of the rab-
bits was determined by lens dry weight measurements as described
previously (18).
EPITOPE BLOCKING ELISA
Virus-specific antibodies to WNVKUN or MVEV were detected in
human plasma and rabbit sera using a blocking ELISA (bELISA)
(19) as detailed in Prow et al. (20). Seropositivity is defined as
inhibition of the binding of virus-specific monoclonal antibodies
(mAb) by more than 30%. All samples were initially screened for
flavivirus antibodies using the anti-flaviviral E protein mAb 4G2 as
the competing antibody (20). All flavivirus positive samples were
then tested for WNVKUN (both human and rabbit samples) and
MVEV (human samples only) using the same bELISA protocols
with the mAbs 3.1112G and 10C6, respectively. Horse sera previ-
ously tested to be positive and negative for the virus of interest (20)
were employed as controls for the bELISA on human plasma, while
serum from naïve SPF-bred New Zealand White rabbits and rab-
bits experimentally infected with WNVNSW2011 (kindly provided
by W. Suen, University of Queensland) were used as negative and
positive controls for the bELISA involving rabbit sera. Controls
consisting of no sera and no antigen (coating buffer only) were
also included in each bELISA.
VIRUS NEUTRALIZATION ASSAY
Samples positive in the bELISA were tested for neutralizing activ-
ity against WNVKUN (rabbit and human samples) and MVEV
(human samples only) in a microtiter serum neutralization assays,
using MVEV (strain 1–51) or WNVKUN (strain MRM16) as
previously described in detail (20).
STATISTICAL ANALYSIS
The proportion seropositive and 95% CI was calculated. For
both human and rabbit data, seropositivity was first compared
across age group, location (state/region), sex (human only), and
time period in univariate analyses using the chi-squared test
or a univariate logistic regression. Where a significant relation-
ship with seropositivity was observed for two or more variables,
these variables were entered into a logistic regression model [with
seropositivity (reactive or non-reactive) as the dependent variable
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FIGURE 1 | Location of sampling areas for human blood donors in NSW, Australia.
(non-reactive as the reference) and the other variables as factors].
Microsoft Excel (Microsoft Pty. Ltd., North Ryde, NSW, Australia)
and the Statistical Package for the Social Sciences (SPSS; IBM
Australia Ltd., St. Leonards, NSW, Australia) were used for data
management and analyses.
.
RESULTS
PROFILE OF THE HUMAN STUDY POPULATIONS
A total of 316 individuals were included in this study, consisting
of 148 in the pre-2011 cohort and 168 in the post-2011 cohort
(Table 1). Just over half (52.2%) of the samples were from male
donors. The median age of donors was 43 years (IQR 26–56)
for the pre-2011 sample group and 51 years (IQR 40.5–61) for
the post-2011 sample group, with a slightly skewed distribution
toward older donors in the post-2011 sample group. The majority
of samples were collected from regional NSW, west of the Great
Dividing Range (Table 1).
SEROPREVALENCE OF FLAVIVIRUSES, WNVKUN, AND MVEV IN HUMAN
BEINGS IN COASTAL NSW
Flavivirus total antibody was detected in 15 of the 148 samples in
the pre-2011 group (10.1%), while 13 of 168 (7.7%) samples were
observed to be seropositive for flavivirus antibody in the post-2011
group (Table 2). Seroprevalence of WNVKUN total antibody in the
pre-2011 samples was 0.7% with just one sample testing seropos-
itive, which is similar to the seroprevalence observed in the post-
2011 samples (0.6%) where again, just one sample was observed
to be seropositive to WNVKUN (Table 2). These two WNVKUN
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seropositive samples were both from males, with ages of 68 and
65, respectively, both of whom were residents of Tamworth in the
North West Slopes subregion of regional NSW. Both WNVKUN
seropositive samples were also tested in the neutralization assay
FIGURE 2 | Known distribution of WNVKUN in Australia and
seroprevalence in Australian rabbits. States and Territories are shown.
Red circles indicate approximate areas of rabbit sampling. Numbers in
brackets represents overall seroprevalence of antibodies to WNVKUN in
rabbits during 2011–2012.
and confirmed to have neutralizing antibodies against WNVKUN
with titers of 40 and 80, respectively. None of the total flavivirus
seropositive samples tested positive for antibodies against MVEV.
No significant difference was observed between pre- and post-
2011 time points in either total flavivirus seropositivity (p= 0.454)
or in WNVKUN seropositivity (p= 0.928). Overall, the propor-
tion of males seropositive for total flavivirus antibody was sig-
nificantly higher than females (p= 0.001); however, age group
(p= 0.146) and region (p= 0.889) did not significantly influence
seropositivity (Table 3).
SEROPREVALENCE OF FLAVIVIRUSES IN RABBITS
Out of a total of 675 rabbits sampled between April 2011 (Southern
Hemisphere Autumn) and November 2012 (Southern Hemisphere
Spring) 86 animals (12.7%) had antibodies specific for WNVKUN
as determined in the 3.111G bELISA (Table 4). Of these, 28 (32.5%
of bELISA positive) rabbits had WNVKUN neutralizing antibodies
with titers varying from 20 to 160, as determined in the microneu-
tralization assay (data not shown). By univariate analysis, there
was a significant association between state (p< 0.001) and time
period (p= 0.050), while age had no apparent effect (p= 0.876).
By multivariate logistic regression, both state (p< 0.001) and
time period (p= 0.018) were still associated with seropositivity
(Table 5). Specifically, the seroprevalence was higher in the states
of Queensland and Victoria compared to Tasmania, and also in
summer 2012 and winter 2012 compared to spring 2012 (Tables 4
and 5; Figures 2 and 3).
Table 1 | Characteristics of the human study population.
Time point/region Number of samples Age group Male (%)
≤24 25–34 35–44 45–54 55–64 ≥65
PRE-2011
Hunter valley/Central Coast/Sydney 16 8 1 2 1 3 1 38
Regional NSW 132 26 20 23 21 22 20 52
Total 148 34 21 25 22 25 21 50
POST-2011
Hunter valley/Central Coast/Sydney 32 4 1 5 11 8 3 59
Regional NSW 136 16 11 20 31 35 23 53
Total 168 20 12 25 42 43 26 54
TOTAL
Hunter valley/Central Coast/Sydney 48 12 2 7 12 11 4 52
Regional NSW 268 42 31 43 52 57 43 52
Total 316 54 33 50 64 68 47 52
Table 2 | Flavivirus seroprevalence in blood donors from eastern NSW collected in the months prior to and soon after the equine 2011 WNVKUN
epidemic.
Time point Number tested Total flavivirus WNVKUN
Positive % (95% CI) Positive % (95% CI)
Pre-2011 148 15 10.1 (5.27–15.00) 1 0.7 (0.00–2.00)
Post-2011 168 13 7.8 (3.70–11.78) 1 0.6 (0.00–1.76)
Overall 316 28 8.9 (5.73–11.99) 2 0.6 (0.00–1.51)
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Table 3 | Breakdown of total flavivirus seropositivity by sex, age group, and region.
Variable Number tested Total flavivirus seropositivity Univariate analysis
n % (95% CI) Odds ratio (95% CI) p-Value
Time period
Pre-2011 148 15 10.1 (5.27–15.00) † –
Post-2011 168 13 7.8 (3.70–11.78) 1.345 (0.618–2.928) 0.456
Sex
Female 151 5 3.3 (0.46–6.17) † –
Male 165 23 13.9 (8.65–19.22) 4.730 (1.750–12.784) 0.002
Age group (years) 0.242
<25 54 1 1.8 (0.00–5.45) † –
25–34 33 3 9.1 (0.00–18.90) 5.30 (0.528–53.237) 0.157
35–44 50 8 16.0 (5.84–26.16) 10.095 (1.214–83.930) 0.032
45–54 64 7 10.9 (3.29–18.58) 6.509 (0.775–54.683) 0.085
55–64 68 7 10.3 (3.07–17.52) 6.082 (0.725–51.044) 0.096
>65 47 2 4.3 (0.00–10.03) 2.356 (0.207–26.840) 0.490
Region group 0.889
Hunter valley/Central coast/Sydney 48 4 8.3 (0.51–16.15) † –
Regional NSW 268 24 9.0 (5.54–12.37) 0.924 (0.306–2.794) 0.889
†Not applicable.
Table 4 | KUN seropositivity in Australian rabbits, from April 2011 to
November 2012.
nTested KUN seropositive
n % (95% CI)
Total 675 86 12.74 (10.23–15.26)
TIME PERIOD
Autumn 2011 86 9 10.5 (4.00–16.93)
Winter 2011 82 10 12.2 (5.11–19.28)
Spring 2011 148 18 12.2 (6.90–17.43)
Summer 2012 145 28 19.3 (12.89–25.74)
Autumn 2012 86 4 4.6 (0.20–9.10)
Winter 2012 66 11 16.7 (7.68–25.66)
Spring 2012 62 6 9.7 (2.32–17.04)
STATE
South Australia 109 4 3.7 (0.14–7.20)
Queensland 59 22 37.3 (24.95–49.63)
New South Wales 294 26 8.8 (5.60–12.09)
Northern Territory 60 7 11.7 (3.54–19.79)
Tasmania 19 1 5.3 (0.00–15.30)
Victoria 94 22 23.4 (14.84–31.96)
Western Australia 40 4 10.0 (0.70–19.30)
AGE (MONTHS)
<3 53 8 15.1 (5.46–24.73)
3–5.9 84 7 8.3 (2.42–14.24)
6–8.9 108 14 13.0 (6.63–19.30)
9–11.9 79 9 11.4 (4.39–18.40)
12–14.9 56 8 14.3 (5.12–23.45)
≥15 278 37 13.3 (9.32–17.30)
N/A 17 3 –
Table 5 | Multivariate logistic regression analysis: influence of factors
on KUN seropositivity in Australian rabbits.
Variable Multivariate logistic regression analysis
Odds ratio 95% CI p-Value
TIME PERIOD (REFERENCE GROUP: SPRING 2012)
Autumn 2011 0.554 0.178–1.721 0.307
Winter 2011 0.635 0.204–1.984 0.435
Spring 2011 0.608 0.219–1.688 0.340
Summer 2012 0.344 0.127–0.928 0.035
Autumn 2012 1.610 0.414–6.258 0.492
Winter 2012 0.275 0.090–0.842 0.024
STATE (REFERENCE GROUP:TASMANIA)
South Australia 1.025 0.104–10.147 0.983
Queensland 0.060 0.007–0.500 0.009
New South Wales 0.363 0.044–2.975 0.345
Northern Territory 0.297 0.033–2.655 0.278
Victoria 0.105 0.013–0.868 0.037
Western Australia 0.256 0.026–2.559 0.246
DISCUSSION
West Nile virus is an on-going global public health concern,
causing large outbreaks in the USA, Europe, and more recently
Australia. Following extensive flooding across Eastern Australia
in 2011 promoting ideal conditions for mosquito breeding, an
unprecedented outbreak of equine encephalitis occurred, leading
to the isolation of the first virulent strain of WNV in Australia.
However, a number of unusual epidemiological features associ-
ated with this outbreak, including the lack of severe human cases,
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previously unseen transmission of WNVKUN in coastal regions
and a number of cases reported outside the areas affected by
heavy rainfall, instigated further studies to try to explain the 2011
outbreak.
Historically, WNVKUN has been associated with only mild
symptoms in humans and horses. The emergence of the
WNVNSW2011 strain suggested the virus may have undergone
changes and evolved to become more virulent and able to cause
fatal encephalitis in horses. However, since no severe human cases
were seen during the outbreak, this study aimed to determine
whether the lack of human involvement in the outbreak was sim-
ply due to pre-existing antibody against WNVKUN. The very low
seroprevalence of WNVKUN in humans observed in samples col-
lected both before (0.7%) and after (0.6%) the 2011 outbreak of
equine flavivirus encephalitis suggest that, in contrast to what was
seen during the WNV incursion into the USA, humans residing
in easternmost NSW were not exposed to the new WNVNSW2011.
However, these seroprevalences are considerably lower than seen
in previous serosurveys conducted in the Murray Valley region of
NSW between 1991 and 2011, where WNVKUN seroprevalences
had been observed to range between 2.2 and 2.5% in the human
population (21, 22). Higher WNVKUN seroprevalence rates, rang-
ing from 2.1 to 3.1%,have also been observed inVictorian residents
(21, 23). It is possible that our results are biased because of the
small sample size relative to previous studies and the fact that we
studied a seemingly health conscious subset of the population, i.e.,
blood donors, who may take measures to limit their exposure to
mosquitoes and thus arbovirus disease in accordance with Public
Health recommendations. This suggestion is also supported by
the absence of antibodies to MVEV despite 16 confirmed cases of
MVEV in humans during 2011, as reported by the National Noti-
fiable Diseases Network (12). However, it should be noted that
the coastal regions of NSW are not typically affected by flavivirus
diseases. Rather, MVEV tends to occur in the Murray Valley basin
and occurrence is governed by rainfall and the resulting migration
of birds. Previous VIC-based studies observed a MVEV seropreva-
lence of 3.7% (n= 2,783) in 1991–1992 and 2.2% (n= 1115) in
2011 (21, 23).
Another factor governing transmission of arboviruses is vec-
tor competence, which is the intrinsic ability for an arthropod
vector to become infected with and transmit an arbovirus (24).
Studies are currently being undertaken to determine whether the
NSW2011 strain of WNVKUN exhibits increased fitness in the
primary vector, Cx. annulirostris, compared to non-pathogenic
strains (van den Hurk et al., personal communication). If the
NSW2011 strain is transmitted more efficiently by mosquitoes,
then increased vector competence of Cx. annulirostris may have
contributed to the equine epidemic, making it even more intrigu-
ing that corresponding increases in human exposures and clinical
cases were not seen.
A large scale serological survey was conducted in the NSW
equine population in late 2011 following cessation of the equine
epidemic (25). This study had two notable findings, firstly that the
overall seroprevalence of WNVKUN in horses was low (3.9% of
1054 horses across the state) and lower than in previous studies.
Secondly, almost all the seropositive horses came from far-western
FIGURE 3 | WNVKUN seroprevalence in feral rabbits in Australia sampled
at the peak (Autumn 2011) and end (Winter 2011) of the equine
encephalitis epidemic (Autumn 2011) and over the following
15 months. Bars represent the proportion of animals seropositive at each
time period, with the bars representing the 95% confidence intervals.
Asterisks represent a significant difference (p<0.05) compared to spring
2012.
districts of NSW (25), while the majority of clinical cases were seen
in the eastern half of NSW (14). This also suggests that infection
with this new strain of WNVKUN was associated with very high
morbidity in the equine population.
In considering the distribution of equine encephalitis cases
in the 2011 epidemic (14), we hypothesized that animal species
other than birds might be involved in the spread of WNVKUN
along the eastern coastal areas of NSW. Notably, this area largely
avoided the flooding events of early 2011 and dry conditions
prevailed in the region during the summer and autumn of
2011. One species with wide distribution across Australia is the
feral rabbit (www.invasiveanimals.com). Rabbits have been shown
experimentally to develop a viremia in the absence of clinical
signs following infection with WNV (16, 17). Interestingly, the
present study revealed a higher seroprevalence in rabbits caught in
Queensland andVictoria, compared to NSW. However, this finding
may be biased due to the sampling areas, with the NSW sampling
area being west of the main region for equine cases [(14); Figure 1].
In contrast, the high seroprevalence in Victorian rabbits is in con-
cordance with the equine epidemic extending into this state, and
the fact that the rabbit sampling area (Hattah-Kulkyne National
Park) was within the region with many equine cases. The find-
ings for Queensland are particularly notable, as this state avoided
the equine encephalitis epidemic despite major flooding (14) and
despite the presence of a susceptible equine population (20). The
lack of correlation between equine clinical cases and seropreva-
lence in rabbits in some areas may be taken to suggest that rabbits
have no role in the transmission cycle. Nevertheless, the finding
that seroprevalence in this species was independent of age may
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suggest that they could be used as sentinels for arbovirus activity
in a particular region. As the rabbit is a pest species in Australia
and various programs are in place to control them, culled ani-
mals could be sampled for serological surveys prior to destruction
and in this way inform Public Health authorities about potential
arbovirus activity in a particular region.
WNV is estimated to have infected approximately four million
humans in North America, causing over 37,000 clinical infections
and 1443 deaths between 1999 and 2012 (4). On-going surveil-
lance of currently circulating WNV strains in North America has
indicated that the virus is continually changing with at least three
different genotypes identified to date. Given that North American
and Australian strains of WNV are very close genetically, sharing
~99% amino acid identity, and all WNV strains share a common
transmission cycle, the possibility of emerging virulent strains of
WNV in Australia, able to induce severe human disease, remains a
definite possibility. In light of the observations from this study, the
Australian population is still vulnerable to these emerging virulent
strains, as very few people appear to have levels of WNVKUN-
specific antibodies sufficient to afford protective immunity.
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